Cargando…
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
Introduction. Metabolic conditions, including type 2 diabetes, have been related to hepatocellular carcinoma (HCC) risk. We have further analyzed the role of diabetes and antidiabetic treatments on HCC. Methods. Data derived from a hospital-based case-control study (Italy, 2005–2012) on 224 HCC pati...
Autores principales: | Miele, Luca, Bosetti, Cristina, Turati, Federica, Rapaccini, Gianlodovico, Gasbarrini, Antonio, La Vecchia, Carlo, Boccia, Stefania, Grieco, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444581/ https://www.ncbi.nlm.nih.gov/pubmed/26074956 http://dx.doi.org/10.1155/2015/570356 |
Ejemplares similares
-
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma
por: Boccia, Stefania, et al.
Publicado: (2015) -
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach
por: Biolato, Marco, et al.
Publicado: (2017) -
Risk factors for breast cancer in China: similarities and differences with western populations
por: Turati, Federica, et al.
Publicado: (2012) -
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
por: Fianchi, Francesca, et al.
Publicado: (2021) -
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)